Diagnostic Accuracy of Xpert MTB/RIF in Tuberculosis Detection

Performance Characteristics

The American Thoracic Society recommends Xpert MTB/RIF as an initial diagnostic test, with a pooled sensitivity of 85% and specificity of 98% in unselected participants 1
In AFB smear-positive patients, a negative NAAT makes TB disease highly unlikely with false-negative results occurring only 4% of the time, according to the Infectious Diseases Society of America 2
For people living with HIV, the estimated pooled sensitivity of Xpert MTB/RIF is 79%, as stated by the American College of Chest Physicians 1, 3
Clinical suspicion remains important in smear-negative patients, as sensitivity decreases substantially, according to the Infectious Diseases Society of America 2, 4

Xpert MTB/RIF provides a robust surrogate marker for multidrug-resistant TB, with a pooled sensitivity of 96% and specificity of 98%, as recommended by the American College of Chest Physicians 1, 3
The positive predictive value of rifampicin resistance detection may be lower in populations with low prevalence of drug resistance, according to the Infectious Diseases Society of America 2

Xpert MTB/RIF significantly increases TB detection among culture-confirmed cases by approximately 23% compared to smear microscopy alone, as stated by the American College of Chest Physicians 1, 3
False-negative results are more common in paucibacillary disease, requiring clinical judgment in cases with high suspicion despite negative results, according to the Infectious Diseases Society of America 2, 4

Xpert MTB/RIF can potentially replace smear microscopy as initial testing in both low and high TB prevalence settings, as recommended by the American College of Chest Physicians 1, 3
Despite higher costs compared to microscopy, the increased case detection justifies implementation as part of comprehensive TB control programs, according to the American College of Chest Physicians 1, 3

GeneXpert substantially outperforms AFB smear microscopy, which has highly variable sensitivity, in respiratory specimens 5
GeneXpert provides comparable accuracy to mycobacterial culture, but with a dramatically faster turnaround time, according to the Clinical Infectious Diseases guideline 5